Total Payments
$12,353
2024 Payments
$1,892
Companies
37
Transactions
735
Medicare Patients
233
Medicare Billing
$13,008
Payment Breakdown by Category
Food & Beverage$12,327 (99.8%)
Education$25.48 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,327 | 731 | 99.8% |
| Education | $25.48 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,355 | 89 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,322 | 106 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,312 | 26 | $0 (2024) |
| Amgen Inc. | $769.85 | 37 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $743.08 | 47 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $665.00 | 36 | $0 (2020) |
| ViiV Healthcare Company | $620.34 | 38 | $0 (2024) |
| PFIZER INC. | $613.81 | 52 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $522.44 | 52 | $0 (2024) |
| Allergan, Inc. | $511.95 | 25 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,892 | 96 | AstraZeneca Pharmaceuticals LP ($324.63) |
| 2023 | $931.74 | 38 | Novartis Pharmaceuticals Corporation ($116.45) |
| 2022 | $298.22 | 4 | GlaxoSmithKline, LLC. ($272.57) |
| 2021 | $398.93 | 6 | GlaxoSmithKline, LLC. ($189.08) |
| 2020 | $871.18 | 42 | Allergan, Inc. ($134.51) |
| 2019 | $3,110 | 211 | AstraZeneca Pharmaceuticals LP ($366.67) |
| 2018 | $2,277 | 135 | GlaxoSmithKline, LLC. ($241.58) |
| 2017 | $2,574 | 203 | Boehringer Ingelheim Pharmaceuticals, Inc. ($566.85) |
All Payment Transactions
735 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $34.39 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: HIV | ||||||
| 12/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: VIROLOGY | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.63 | General |
| 11/22/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: OUD | ||||||
| 11/20/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: HIV | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.95 | General |
| 11/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: HIV | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.34 | General |
| 10/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: VIROLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $1.37 | General |
| Category: VIROLOGY | ||||||
| 09/30/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $3.12 | General |
| Category: HIV | ||||||
| 09/26/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: HIV | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.30 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 82 | 91 | $12,673 | $4,469 |
| 2022 | 2 | 44 | 47 | $6,398 | $2,884 |
| 2021 | 2 | 49 | 53 | $6,181 | $2,901 |
| 2020 | 2 | 58 | 61 | $7,872 | $2,754 |
Total Patients
233
Total Services
252
Medicare Billing
$13,008
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 52 | 60 | $9,488 | $3,184 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 30 | 31 | $3,185 | $1,285 | 40.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 29 | 30 | $4,674 | $2,199 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 15 | 17 | $1,724 | $685.56 | 39.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 22 | 24 | $3,460 | $1,551 | 44.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 27 | 29 | $2,721 | $1,350 | 49.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 40 | 42 | $6,080 | $2,062 | 33.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 18 | 19 | $1,791 | $691.89 | 38.6% |
About Dr. Roy Gill, MD
Dr. Roy Gill, MD is a Internal Medicine healthcare provider based in Johnson City, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831190867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roy Gill, MD has received a total of $12,353 in payments from pharmaceutical and medical device companies, with $1,892 received in 2024. These payments were reported across 735 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($12,327).
As a Medicare-enrolled provider, Gill has provided services to 233 Medicare beneficiaries, totaling 252 services with total Medicare billing of $13,008. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Johnson City, NY
- Active Since 08/01/2005
- Last Updated 11/19/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1831190867
Products in Payments
- JARDIANCE (Drug) $908.24
- ENTRESTO (Drug) $491.19
- TRELEGY ELLIPTA (Drug) $419.40
- Vascepa (Drug) $412.25
- Prolia (Biological) $401.46
- XARELTO (Drug) $352.70
- DOVATO (Drug) $333.17
- TOUJEO (Drug) $314.45
- VRAYLAR (Drug) $304.03
- CHANTIX (Drug) $293.54
- BEVESPI AEROSPHERE (Drug) $291.19
- SHINGRIX (Biological) $254.49
- LEQVIO (Drug) $251.89
- ELIQUIS (Drug) $241.43
- BREZTRI (Drug) $239.45
- SOLIQUA (Drug) $230.40
- EVENITY (Biological) $226.50
- BREO (Drug) $222.19
- Ozempic (Drug) $215.44
- FARXIGA (Drug) $213.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Johnson City
Ronald Hamdy, Md, MD
Internal Medicine — Payments: $106,675
Internal Medicine $106,675
Fawwaz Hamati, Md, MD
Internal Medicine — Payments: $64,697
Internal Medicine $64,697
Dr. Hesham Hazin, M.d, M.D
Internal Medicine — Payments: $64,317
Internal Medicine $64,317
Dr. Keyoor Patel, Do, Facc, DO, FACC
Internal Medicine — Payments: $34,573
Internal Medicine $34,573
Celso Ebeo, M.d, M.D
Internal Medicine — Payments: $18,950
Internal Medicine $18,950
Dr. Mihir Patel, Md, MD
Internal Medicine — Payments: $15,302
Internal Medicine $15,302